FMO5 and acute myeloid leukemia: For example, RUNX1-ETO has previously been shown to independently induce ROS and senescence-like growth arrest61, hinting that additional ROS generation through Rac/NADPH oxidase activity may have detrimental effects on t(8;21) AML cell growth.